Document is current
Any future updates will be listed below
-
Authors
Zhang, Xuan https://orcid.org/0000-0002-4276-6464
Guseinov, Abdul-Akim https://orcid.org/0000-0002-2796-4323
Jenkins, Laura https://orcid.org/0000-0003-1382-8547
Valentini, Alice
Marsango, Sara
Schultz-Knudsen, Katrine
Ulven, Trond
Rexen Ulven, Elisabeth https://orcid.org/0000-0003-1243-7587
Tikhonova, Irina G. https://orcid.org/0000-0002-6228-9431
Milligan, Graeme https://orcid.org/0000-0002-6946-3519
Zhang, Cheng https://orcid.org/0000-0001-9042-4007
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 22 May 2025
First Online: 18 June 2025
Competing interests
: G.M. and T.U. are co-founders and directors of Caldan Therapeutics (). G.M. is a co-founder and director of KelticPharmaTherapeutics (). Both companies have interests in the development of FFA4 activators. The other authors declare no competing interests.
